Scientists say that blocking a protein called DLK could help protect against neurodegeneration of demyelinated nerve cells in ...

People with multiple sclerosis (MS) often stop taking disease-modifying ... patients tend to experience fewer relapses and less disease activity but show more evidence of neuronal degeneration.

Reference: “Neuroprotective effect of neuron-specific deletion of the C16 ceramide synthetic enzymes in an animal model of ...

Approximately 5,000 people in the U.S. develop amyotrophic lateral sclerosis (ALS) each year. On average, they survive for only two to five years after being diagnosed, according to the Centers for ...

Mapping cell types in MS lesions reveals unique tissue niches and interactions, offering insights into the molecular drivers ...